Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Sterile Addition of Feeds and Supplements in Bioreactor Operations – V 2.0

Posted on By


Biosimilars: SOP for Sterile Addition of Feeds and Supplements in Bioreactor Operations – V 2.0


Standard Operating Procedure for Sterile Addition of Feeds and Supplements in Bioreactor Operations for Biosimilars

Department Biosimilars
SOP No. SOP/BS/097/2025
Supersedes SOP/BS/097/2022
Page No. Page 1 of 12
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To establish a validated, sterile method for the addition of feeds, buffers, and supplements to bioreactor systems during biosimilar production. This ensures aseptic conditions and prevents contamination that could compromise batch quality.

2. Scope

This SOP applies to all operations involving the transfer of nutrient feeds, glucose solutions, pH adjustment buffers, and other additives into both single-use and stainless-steel bioreactors in the biosimilars manufacturing unit.

3. Responsibilities

  • Manufacturing Operator: Prepare, filter, and transfer solutions using sterile connections.
  • QA Officer: Review batch records and ensure sterile practices are adhered to.
  • Engineering: Ensure sterilization validation of equipment and connection lines.

4. Accountability

The Head of Manufacturing is accountable for ensuring sterile handling, equipment integrity, and operator compliance during feed addition processes.

5. Procedure

5.1 Preparation of Feed Solutions

  1. Weigh and dissolve raw materials (glucose, amino acids, salts) in WFI using a validated mixing tank.
  2. Filter final solution using a 0.22 μm sterile-grade filter into a pre-sterilized feed bag or bottle.
  3. Label feed container with solution name, batch number, preparation date, and expiry (max 24 hours).

5.2 Bioreactor Port Preparation

  1. Ensure that the bioreactor port for feed addition (e.g., Luer-lock, CPC) is sterile and capped.
  2. Sanitize port exterior with 70% IPA prior to connection.

5.3 Sterile Connection Process

  1. Use one of the following validated sterile connection methods:
    • Pre-sterilized tube welding (for single-use systems)
    • Steam-in-place (SIP) transfer lines for SS bioreactors
    • Aseptic quick-connects (e.g., Kleenpak, AseptiQuik)
  2. Perform connections in a Grade A/B laminar flow or controlled area.

5.4 Feed Addition Execution

  1. Open transfer line valves slowly to minimize pressure fluctuations.
  2. Record the exact time, volume, and feed solution details in the batch record (Annexure-1).
  3. Monitor bioreactor parameters (pH, DO, temperature) during and after addition.

5.5 Post-Addition Actions

  1. Disconnect the transfer line using aseptic techniques and reseal the port if required.
  2. Dispose of used tubing and feed containers as per biohazard protocols.
  3. Retain a sample of the feed solution for QC analysis (sterility, osmolality, composition).

6. Abbreviations

  • WFI: Water for Injection
  • IPA: Isopropyl Alcohol
  • SIP: Sterilize-In-Place
  • QC: Quality Control

7. Documents

  1. Feed Addition Log – Annexure-1
  2. Sterile Connection Checklist – Annexure-2

8. References

  • ICH Q7 – GMP for Active Pharmaceutical Ingredients
  • WHO TRS 1010 Annex 4 – Good Manufacturing Practices for Biological Products

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Feed Addition Log

Date Batch No. Feed Name Volume (mL) Added By Time
04/05/2025 BS-215 Glucose 40% 500 Sunita Reddy 10:30 AM

Annexure-2: Sterile Connection Checklist

Connection Method Probe Sterilized Environment Grade Integrity Test Performed By Date
AseptiQuik Yes Grade B Pass Rajesh Kumar 04/05/2025

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Included sterile tubing methods and new annexures Compliance enhancement
See also  Biosimilars: SOP for Vector Design and Cloning - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Gel Manufacturing: SOP for Viscosity Testing of Gel Formulations – V 2.0
Next Post: Sterile Injectable Manufacturing: SOP for Handling Sterile Components during Manufacturing – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version